T

Trimurthi Ltd
BSE:536565

Watchlist Manager
Trimurthi Ltd
BSE:536565
Watchlist
Price: 63.75 INR 2.03% Market Closed
Market Cap: ₹344.1m

Net Margin

-6.1%
Current
Declining
by 1.9%
vs 3-y average of -4.2%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-6.1%
=
Net Income
₹-1.7m
/
Revenue
₹28.7m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-6.1%
=
Net Income
₹-1.7m
/
Revenue
₹28.7m

Peer Comparison

Country Company Market Cap Net
Margin
IN
Trimurthi Ltd
BSE:536565
344.1m INR
Loading...
US
Mckesson Corp
NYSE:MCK
119.6B USD
Loading...
US
Cencora Inc
NYSE:COR
70.6B USD
Loading...
US
Amerisourcebergen Corp
LSE:0HF3
69.5B USD
Loading...
US
Cardinal Health Inc
NYSE:CAH
53.4B USD
Loading...
AU
Sigma Healthcare Ltd
ASX:SIG
35.9B AUD
Loading...
US
Henry Schein Inc
NASDAQ:HSIC
9.5B USD
Loading...
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
64B CNY
Loading...
CN
Huadong Medicine Co Ltd
SZSE:000963
63.8B CNY
Loading...
CN
Sinopharm Group Co Ltd
HKEX:1099
65.6B HKD
Loading...
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW
Loading...

Market Distribution

Lower than 87% of companies in India
Percentile
13th
Based on 5 531 companies
13th percentile
-6.1%
Low
-305 007.7% — 2.1%
Typical Range
2.1% — 11.6%
High
11.6% — 1 221 633.3%
Distribution Statistics
India
Min -305 007.7%
30th Percentile 2.1%
Median 5.8%
70th Percentile 11.6%
Max 1 221 633.3%

Trimurthi Ltd
Glance View

Market Cap
344.1m INR
Industry
Health Care

Trimurthi Ltd. operates as a holding company, which engages in the distribution, retail, and marketing of pharmaceutical products. The company is headquartered in Hyderabad, Telangana. The firm is primarily engaged in the business of pharmaceutical distribution and retail pharmacy. Its segments include Pharma Business, Financial Activity, Investment Activity and Trading in Shares. The Company’s services include a distribution network for pharmaceutical products, retail pharmacy and marketing. Its products include ULCIZOL, OXYMIN, Volivia Gold, Conplus, Oriflox, Treb-DSR, ACLO-P and LAMITAB. The firm has its pharmacy retail outlets in Himayath Nagar and Inderbagh, Sultan Bazar in Hyderabad. The company has its operations in the state of West Bengal and has its presence in the eastern part of India. Trimurthi Pharmaceuticals (India) Private Limited is the Company’s subsidiary.

TRIMURTHI Intrinsic Value
7.7 INR
Overvaluation 88%
Intrinsic Value
Price
T
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-6.1%
=
Net Income
₹-1.7m
/
Revenue
₹28.7m
What is Trimurthi Ltd's current Net Margin?

The current Net Margin for Trimurthi Ltd is -6.1%, which is below its 3-year median of -4.2%.

How has Net Margin changed over time?

Over the last 3 years, Trimurthi Ltd’s Net Margin has increased from -32.5% to -6.1%. During this period, it reached a low of -185.1% on Mar 31, 2022 and a high of 0.2% on Mar 31, 2024.

Back to Top